Chemed Corp

Chemed Corp(CHE)股票分析

$516.070

+7.896 (+1.53%)收盘时

Loading chart…
最高
519.270
开盘
511.280
成交量加权均价
513.78
成交量
114.13K
市值
8.22B
最低
506.010
成交额
58.64M
企业价值/息税折旧摊销前利润(TTM)
15.45

Chemed Corporation is engaged in purchasing, operating, and divesting subsidiaries in diverse business activities. The Company's segment includes VITAS and the Roto-Rooter. The VITAS segment provides hospice and palliative care services to its patients through a network of physicians, registered nurses, home health aides, social workers, clergy and volunteers. It provides direct medical services to patients, as well as spiritual and emotional counseling to both patients and their families. The Roto-Rooter segment provides plumbing, drain cleaning, excavation, water restoration and other related services to residential and commercial customers. The Roto-Rooter services are provided through a network of Company-owned branches, independent contractors and franchisees. The Company's water restoration services involve the remediation of water and humidity after a flood and are provided to both commercial and residential customers.

AI 分析 of Chemed Corp (CHE)

买入

Chemed Corp is a good buy right now due to its current price of $512.38, which is below the median analyst price target of $549, indicating a potential upside of 7.1%. Additionally, the company has shown a strong year-to-date change of +20.90%, reflecting solid performance. However, a risk to consider is the insider selling activity, where an executive sold 1,000 shares, reducing holdings by 7%, which could signal caution among insiders.

分析师评级(4)

上行空间 +6.06%
持有
1 买入
3 持有
0 卖出
当前: 516.07
最低
475.00
平均
547.33
最高
595.00

UBS

2026-09-25

目标价

$650

买入

Oppenheimer

2026-07-31

目标价

$590

跑赢大盘

RBC Capital

2026-07-30

目标价

$548

Sector Perform

BofA

2026-07-09

目标价

$510

中性

RBC Capital

2026-04-27

目标价

$436

Sector Perform

估值指标

Chemed Corp(CHE)当前预期市盈率为 18.18,5 年平均预期市盈率为 22.79。

预期市盈率

低估
5 年均值 P/E
22.79
当前P/E
18.18
高估
25.62
低估
19.96

预期 EV/EBITDA

合理
5 年均值 EV/EBITDA
15.66
当前EV/EBITDA
15.45
高估
17.42
低估
13.90

预期市销率

低估
5 年均值 P/S
3.09
当前P/S
2.30
高估
3.63
低估
2.56

Alphio AI 对 CHE 的价格情景

情景价格取自当年最后一个月度预测区间。概率为固定的模型权重(25 / 50 / 25),不构成保证。

乐

乐观

乐观 · 25%CHE

$709.68

情景价格

基

基准

基准 · 50%CHE

$700.04

情景价格

悲

悲观

悲观 · 25%CHE

$601.39

情景价格

持有 CHE 的大户

V

Van Berkom and Associates Inc.

+ 持有CHE

+2.18%

3个月收益率

B

Boston Trust Walden National Association

+ 持有CHE

-2.52%

3个月收益率

C

Copeland Capital Management, LLC

+ 持有CHE

-6.80%

3个月收益率

E

Eversept Partners, L.P.

+ 持有CHE

-7.76%

3个月收益率

事件时间线

2026-08-06 (ET)

12:00:00

Chemed Corporation Declares Quarterly Cash Dividend of $0.70 per Share

2026-07-28 (ET)

16:30:00

Company Reports Q2 Revenue of $673.25M, Beating Consensus

16:30:00

Company Revises Guidance, Expected EPS at $24.34

2026-04-23 (ET)

16:30:00

VITAS Raises 2026 Earnings Guidance to $24.00 to $24.75 per Share

资讯

CHE 常见问题 —— 由 Alphio AI 解答

Chemed Corporation is engaged in purchasing, operating, and divesting subsidiaries in diverse business activities. The Company's segment includes VITAS and the Roto-Rooter. The VITAS segment provides hospice and palliative care services to its patients through a network of physicians, registered nurses, home health aides, social workers, clergy and volunteers. It provides direct medical services to patients, as well as spiritual and emotional counseling to both patients and their families. The Roto-Rooter segment provides plumbing, drain cleaning, excavation, water restoration and other related services to residential and commercial customers. The Roto-Rooter services are provided through a network of Company-owned branches, independent contractors and franchisees. The Company's water restoration services involve the remediation of water and humidity after a flood and are provided to both commercial and residential customers. It operates in the Healthcare sector (SERVICES-HOME HEALTH CARE SERVICES industry).

Chemed Corp is a good buy right now due to its current price of $512.38, which is below the median analyst price target of $549, indicating a potential upside of 7.1%. Additionally, the company has shown a strong year-to-date change of +20.90%, reflecting solid performance. However, a risk to consider is the insider selling activity, where an executive sold 1,000 shares, reducing holdings by 7%, which could signal caution among insiders.

4 analysts cover CHE: 1 rate it Buy, 3 Hold and 0 Sell. The average price target is 547.33.

暂无帖子

注册或登录后参与讨论

本页仅供研究参考,不构成投资建议。模型可能出错。过往表现不代表未来结果。

开始交易